Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

Clinical trial NCT06138561 · RECRUITING

Trial details

NCT number: NCT06138561
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Bladder Cancer Metastatic Bladder Cancer Unresectable Bladder Carcinoma Urothelial Carcinoma

Start date: 2024-03-05
Primary completion: 2027-07-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.